Document is current
Any future updates will be listed below
-
Authors
Kearney, Helen https://orcid.org/0009-0007-9901-3221
Rak-Raszewska, Aleksandra https://orcid.org/0000-0002-2399-4410
Seijas-Gamardo, Adrián https://orcid.org/0000-0002-8950-367X
Escarda-Castro, Enrique https://orcid.org/0000-0001-6661-9963
Caiment, Florian https://orcid.org/0000-0002-3325-0466
Wieringa, Paul https://orcid.org/0000-0002-3290-5125
Moroni, Lorenzo https://orcid.org/0000-0003-1298-6025
Mota, Carlos https://orcid.org/0000-0001-5935-6245
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (860715)
H2020 Future and Emerging Technologies (964452)
HORIZON EUROPE Marie Sklodowska-Curie Actions (101106539)
- License Information
-
More Information
Article History
Received: 7 February 2025
Accepted: 19 August 2025
First Online: 18 September 2025
Declarations
:
: LUMC0031iCTRL08: LUMCi004-C (RRID: CVCL_ZA01) () were generated from exfoliated renal epithelial cells with commercially available episomal plasmid. Cells were isolated from human samples with informed consent and ethics approval in compliance with the relevant laws. The hiPSC lines HUMIMC101: TISSUi001-A (RRID: CVCL_WU56) () and HUMIMC107: TISSUi007-A (RRID: CVCL_WU62) () were derived from peripheral blood mononuclear cells. Human blood samples were donated with informed consent and ethics approval in compliance with the relevant laws.
: Approval and consent for hiPSCs-lines has been secured by the respective entities that generated the cells.
: All authors have given their consent for the publication of the manuscript.
: The authors declare that they have no conflict of interest.
